| ABCELLERA BIOLOGICS |
| Kanada |
| Gesundheit |
| CA00288U1066 / A2QKXS |
| 8QQ (Frankfurt) / ABCL (NASDAQ) |
| FRA:8QQ, ETR:8QQ, 8QQ:GR, NASDAQ:ABCL |
| - |
| https://www.abcellera.com.. |
|
AbCellera Biologics Inc. operates as a biotechnology company, focusing on the discovery and development of antibody therapies. As a premier firm in the biotech sector, its primary function is to harne..
>Volltext.. |
| 770.35 Mio. EUR |
| 447.52 Mio. EUR |
| 30 Mio. EUR |
| -192.36 Mio. EUR |
| -145.81 Mio. EUR |
| -0.49 EUR |
| 120.79 Mio. EUR |
| 91.87 Mio. EUR |
| -88.52 Mio. EUR |
| 7.57 |
| 1.68% |
| 7.34% |
| - |
| - |
| - |
| - |
| ABCELLERA |
| 25.02.26 |
|
||||
|
||||
|